デフォルト表紙
市場調査レポート
商品コード
1439949

造影剤注入器 - 世界市場の考察、競合情勢、市場予測(2030年)

Contrast Media Injectors - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
造影剤注入器 - 世界市場の考察、競合情勢、市場予測(2030年)
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の造影剤注入器の市場規模は、2022年に11億7,200万米ドル、2030年までに15億400万米ドルに達し、2024年~2030年の予測期間にCAGRで4.27%の成長を記録する可能性が高いです。市場は、主にがん、神経、心血管などのさまざまな慢性疾患の増加により、大幅な市場成長を示しています。さらに、慢性疾患にかかりやすい老年人口の増加、若者の不健康で座りがちな生活習慣の急増、低侵襲手術の需要の増加、シリンジレス注入器や投与量記録システムなどの技術の進歩、製品の発売や承認の増加、主要企業による投資の急増なども、予測期間に造影剤注入器の需要にプラスの影響を与える見込みです。したがって、市場は2024年~2030年の予測期間に大幅なCAGRで成長すると推定されます。

造影剤注入器の市場力学

世界保健機関(WHO)(2022)のファクトシートによると、2020年の乳がんの新規症例数は226万件、次いで肺がん221万件、大腸がん193万件、前立腺がん141万件、皮膚がん120万件、胃がん109万件となっています。造影剤注入器は、腫瘍の正常および病理解剖学的な構造を適切に可視化し、がん患者に造影剤を注入するために使用されます。

がんの場合、新たに異常な血管が発生することがあり、その血管は正常な毛細血管よりも漏れやすい傾向があります。このような場合、注入器を使って造影剤を注入して診断すれば、その他の診断方法と比較して、造影スキャナーで病変をより鮮明に確認することができます。したがって、がんの有病率の増加は、最終的に造影剤注入器の需要を増加させます。

心血管疾患は、世界の死因の第一位と考えられています。WHO(2022)のデータによると、2019年に推定1,790万人が心血管障害で死亡しており、これは世界の全死亡の32%であることを示しています。2019年の非伝染性疾患による1,700万人の早死(70歳未満)のうち、38%が心血管障害によるものでした。画像診断機器を用いて適切な時期に心血管疾患の適切な診断が行われれば、増加する死亡率を減少させることができます。画像診断では、解剖学的構造を適切に可視化するために、造影剤注入器の助けを借りて造影剤が注入されます。したがって、予測期間の造影剤注入器の需要に影響を与えます。

さらに、造影剤の無駄を減らし、患者の投与量に関するデータ収集を自動化するために、造影剤注入器において複数の技術の進歩がなされています。例えば、自動注入器システムは、造影剤の使用量を正確に収集します。ベンダーは、EMRやPACSからのデータを利用することで、患者に合わせた投与量を提供します。シリンジレス注入器は、造影剤の無駄を減らすためのそのような進歩の1つです。また、ほとんどのメーカーは、造影剤の無駄を減らし、競合優位性を得るために新製品に取り組んでいます。例えば、Braccoのスマートシリンジレス注入器は、システムに装填された造影剤を一滴残らず使用し、最大限の効率を実現します。スマート注入器は、注入量だけでなく、使用されたイメージングプロトコルを記録し、データをPACSに送信します。造影剤注入器技術における、こうした絶え間ない技術の進歩が予測期間の市場を後押しする見込みです。したがって、上記の要因が総合的に、2024年~2030年の予測期間に造影剤注入器市場全体を牽引します。

ただし、造影剤注入器と消耗品の高いコストや、造影剤の副作用などが、造影剤注入器市場の成長にとっての課題となる可能性があります。

造影剤注入器市場は、COVID-19パンデミックの時期に大きな影響を受け、多くの放射線科で画像診断の症例数が激減しました。COVID-19パンデミックにより、命を救う画像診断を待つことを余儀なくされた患者は、医療施設へのアクセスに影響を受けました。さらに、造影剤注入器の需要は、厳格なロックダウン規制が課され、製造、サプライチェーン、労働力が混乱したため、不名誉な事態に見舞われました。しかし、ロックダウン規制の緩和、リソースとサプライチェーンの好転、大衆へのワクチン投与、病院や画像診断センターへの患者の復帰により、造影剤注入器の需要が増加し、市場成長を促進しています。

当レポートでは、世界の造影剤注入器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 造影剤注入器市場レポートのイントロダクション

第2章 造影剤注入器市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 造影剤注入器市場の主な要因の分析

  • 造影剤注入器市場の促進要因
  • 造影剤注入器市場の抑制要因と課題
  • 造影剤注入器市場の機会

第5章 造影剤注入器市場のポーターのファイブフォース分析

第6章 造影剤注入器市場に対するCOVID-19の影響分析

第7章 造影剤注入器市場レイアウト

  • 製品別
    • 注入器システム
    • 消耗品
  • 注入器タイプ別
    • シングルヘッド注入器
    • デュアルヘッド注入器
    • シリンジレス注入器
  • 用途別
    • 放射線
    • 心臓インターベンション
    • その他
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 造影剤注入器市場の企業と製品のプロファイル

  • GE HealthCare
  • Bracco
  • MEDTRON AG
  • Ulrich GmbH & Co. KG
  • Bayer Pharmaceuticals
  • Nemoto Kyorindo co., Ltd.
  • SINO MDT
  • APOLLO RT Co. Ltd.
  • Shenzhen Seacrown Electromechanical Co., Ltd.
  • HONG KONG MEDI CO LIMITED

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Contrast Media Injectors Market
  • Table 3: Contrast Media Injectors Market Analysis in Global (2021-2030)
  • Table 4: Contrast Media Injectors Market Analysis in Global by Product (2021-2030)
  • Table 5: Contrast Media Injectors Market Analysis in Global by Type of Injectors (2021-2030)
  • Table 6: Contrast Media Injectors Market Analysis in Global by Application (2021-2030)
  • Table 7: Contrast Media Injectors Market Analysis in Global by Geography (2021-2030)
  • Table 8: Contrast Media Injectors Market Analysis in North America (2021-2030)
  • Table 9: Contrast Media Injectors Market Analysis in North America by Country (2021-2030)
  • Table 10: Contrast Media Injectors Market Analysis in the US (2021-2030)
  • Table 11: Contrast Media Injectors Market Analysis in Canada (2021-2030)
  • Table 12: Contrast Media Injectors Market Analysis in Mexico (2021-2030)
  • Table 13: Contrast Media Injectors Market Analysis in Europe (2021-2030)
  • Table 14: Contrast Media Injectors Market Analysis in Europe by Country (2021-2030)
  • Table 15: Contrast Media Injectors Market Analysis in France (2021-2030)
  • Table 16: Contrast Media Injectors Market Analysis in Germany (2021-2030)
  • Table 17: Contrast Media Injectors Market Analysis in the UK (2021-2030)
  • Table 18: Contrast Media Injectors Market Analysis in Italy (2021-2030)
  • Table 19: Contrast Media Injectors Market Analysis in Spain (2021-2030)
  • Table 20: Contrast Media Injectors Market Analysis in the Rest of Europe (2021-2030)
  • Table 21: Contrast Media Injectors Market Analysis in Asia-Pacific (2021-2030)
  • Table 22: Contrast Media Injectors Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 23: Contrast Media Injectors Market Analysis in China (2021-2030)
  • Table 24: Contrast Media Injectors Market Analysis in Japan (2021-2030)
  • Table 25: Contrast Media Injectors Market Analysis in India (2021-2030)
  • Table 26: Contrast Media Injectors Market Analysis in Australia (2021-2030)
  • Table 27: Contrast Media Injectors Market Analysis in South Korea (2021-2030)
  • Table 28: Contrast Media Injectors Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 29: Contrast Media Injectors Market Analysis in the Rest of the World (2021-2030)
  • Table 30: Contrast Media Injectors Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 31: Contrast Media Injectors Market Analysis in the Middle East (2021-2030)
  • Table 32: Contrast Media Injectors Market Analysis in Africa (2021-2030)
  • Table 33: Contrast Media Injectors Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Contrast Media Injectors Market
  • Figure 3: Contrast Media Injectors Market Analysis in Global (2021-2030)
  • Figure 4: Contrast Media Injectors Market Analysis in Global by Product (2021-2030)
  • Figure 5: Contrast Media Injectors Market Analysis in Global by Type of Injectors (2021-2030)
  • Figure 6: Contrast Media Injectors Market Analysis in Global by Application (2021-2030)
  • Figure 7: Contrast Media Injectors Market Analysis in Global by Geography (2021-2030)
  • Figure 8: Contrast Media Injectors Market Analysis in North America (2021-2030)
  • Figure 9: Contrast Media Injectors Market Analysis in North America by Country (2021-2030)
  • Figure 10: Contrast Media Injectors Market Analysis in the US (2021-2030)
  • Figure 11: Contrast Media Injectors Market Analysis in Canada (2021-2030)
  • Figure 12: Contrast Media Injectors Market Analysis in Mexico (2021-2030)
  • Figure 13: Contrast Media Injectors Market Analysis in Europe (2021-2030)
  • Figure 14: Contrast Media Injectors Market Analysis in Europe by Country (2021-2030)
  • Figure 15: Contrast Media Injectors Market Analysis in France (2021-2030)
  • Figure 16: Contrast Media Injectors Market Analysis in Germany (2021-2030)
  • Figure 17: Contrast Media Injectors Market Analysis in the UK (2021-2030)
  • Figure 18: Contrast Media Injectors Market Analysis in Italy (2021-2030)
  • Figure 19: Contrast Media Injectors Market Analysis in Spain (2021-2030)
  • Figure 20: Contrast Media Injectors Market Analysis in the Rest of Europe (2021-2030)
  • Figure 21: Contrast Media Injectors Market Analysis in Asia-Pacific (2021-2030)
  • Figure 22: Contrast Media Injectors Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 23: Contrast Media Injectors Market Analysis in China (2021-2030)
  • Figure 24: Contrast Media Injectors Market Analysis in Japan (2021-2030)
  • Figure 25: Contrast Media Injectors Market Analysis in India (2021-2030)
  • Figure 26: Contrast Media Injectors Market Analysis in Australia (2021-2030)
  • Figure 27: Contrast Media Injectors Market Analysis in South Korea (2021-2030)
  • Figure 28: Contrast Media Injectors Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 29: Contrast Media Injectors Market Analysis in the Rest of the World (2021-2030)
  • Figure 30: Contrast Media Injectors Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 31: Contrast Media Injectors Market Analysis in the Middle East (2021-2030)
  • Figure 32: Contrast Media Injectors Market Analysis in Africa (2021-2030)
  • Figure 33: Contrast Media Injectors Market Analysis in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Market Opportunities
  • Figure 37: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0630

Contrast Media Injectors Market By Product (Injector Systems [Ct Injector Systems, Mri Injector Systems, And Cardiovascular/Angiography Injector Systems] And Consumables [Tubing, Syringe, And Other]), By Type Of Injectors (Single-Head Injectors, Dual-Head Injectors, And Syringeless Injectors), By Application (Radiology, Interventional Cardiology, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic diseases across the globe and surging demand of minimally invasive surgeries

The global contrast media injectors market was valued at USD 1,172 million in 2022 and is likely to register a CAGR of 4.27% during the forecast period from 2024 to 2030 to reach USD 1,504 million by 2030. The contrast media injectors market is observing significant market growth primarily owing to the mounting figures of various chronic diseases such as cancers, neurological, and cardiovascular among others. Further, an increase in the geriatric population base prone to chronic diseases, surging unhealthy and sedentary lifestyles among youngsters, increasing demand for minimally invasive surgeries, technological advancements such as syringeless injectors and dose recording systems, increasing product launches and approvals, surging investments by key players, and others will also affect the demand for contrast media injectors positively during the forecast period. Therefore, the market of contrast media injectors is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Contrast Media Injectors Market Dynamics:

According to World Health Organization (WHO) 2022 factsheet, the new cases of breast cancer in 2020 was 2.26 million, followed by lung cancer with 2.21 million cases, colon and rectum cancer reported 1.93 million new cases, prostate cancer with 1.41 million cases, skin cancer - with 1.20 million cases, and stomach cancer with 1.09 million cases, worldwide. Contrast media injectors are used to inject contrast media into cancer patients for proper visualization of normal and pathologic anatomy of tumor.

In case of cancers, new abnormal blood vessels may develop, which tend to be leakier than normal capillaries. In this case, if the contrast media is injected using injectors for diagnosis then the lesion can be much more visible on contrast enhanced scaners as compared to the other diagnosis method. Thus, the increasing prevalence of cancer will ultimately increase the demand for contrast media injectors.

Cardiovascular diseases are considered to be the leading cause of death globally. As per the WHO 2022 data, an estimated 17.9 million people died from cardiovascular disorders in 2019, illustrating 32% of all global deaths. Out of the 17 million premature deaths (under the age of 70 years) due to non-communicable diseases in 2019, 38% of the deaths were caused due to cardiovascular disorders. The increasing mortality can be reduced if proper diagnosis of cardiovascular diseases is done at an apt time using imaging devices. During imaging diagnosis contrast media is injected with the help of contrast media injectors to get proper visualization of the anatomy. Thus, affecting the demand for contrast media injectors during the forecast period.

Further, several advances in contrast media injector technology have been made to reduce contrast media waste and automate data collection about a patient's dose. Automated injector systems, for example, precisely collect the amount of contrast media used. Vendors provide personalized doses to patients by utilizing data from EMR or Picture Archiving and Communication System (PACS). Syringeless injectors are one such advancement in reducing contrast media waste. Also, most of the manufacturers are working on new products to reduce contrast media waste and gain a competitive advantage. For instance, Bracco's smart syringeless injectors that use every drop of contrast loaded into the system for maximum efficiency. Smart injectors record the amount injected as well as the imaging protocol used and transmit the data to the PACS. In contrast to media injector technology, these constant technological advancements are expected to boost the market during the forecast period. Therefore, the factors stated above collectively will drive the overall contrast media injectors market during the forecast period from 2024-2030.

However, the high cost of contrast media injectors and consumables, adverse effects of contrast agents, and others may prove to be challenging factors for contrast media injectors' market growth.

The contrast media injectors market was significantly impacted during the period of COVID- 19 pandemic as the volume of imaging cases in many radiology departments dropped dramatically. The COVID-19 outbreak impacted patients' access to healthcare facilities as the pandemic forced them to wait for lifesaving imaging procedures. Moreover, the demand for contrast media injectors suffered a disgrace owing to the imposition of strict lockdown rules, and disruption in manufacturing, supply chain, and workforce. However, with the ease of lockdown restrictions, the upturn of resources and supply chain, the administration of a vaccine to the public, and the return of patients to hospitals or diagnostic imaging centers, the demand for contrast media injectors increased and is driving the market growth.

Contrast Media Injectors Market Segment Analysis:

Contrast Media Injectors Market by Product (Injector Systems [CT Injector Systems, MRI Injector Systems, and Cardiovascular/Angiography Injector Systems] and Consumables [Tubing, Syringe, and Other]), Type of Injectors (Single-Head Injectors, Dual-Head Injectors, and Syringeless Injectors), Application (Radiology, Interventional Cardiology, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the contrast media injectors market, the CT Injector Systems segment is expected to have a significant revenue share in the year 2023. This is owing to its widespread use in the detection and treatment of vascular disease, cancer, and orthopedic injuries and disorders. Moreover, technological advancements and the launch of new products are further expected to propel the growth of the segment.

CT injectors are expected to grow in popularity as the use of CT systems has increased. During imaging, these CT systems employ a dual-head injector with two syringes for initial and follow-up contrast doses. Major academic institutions and pharmaceutical companies have been engaged in continuous R&D to develop protocols that assist CT users with the advanced capabilities of newer imaging systems.

Furthermore, major players are gradually implementing various strategies, such as collaborative initiatives to remain competitive in the market. For instance, in September 2019, The MedradStellant Flex CT injectable system from Bayer was released. The Stellant Flex system is a user-driven system with little technician training and automation. It provides personalized patient protocols and personalized imaging, as well as flexible capital equipment alternatives through the company's TechCare service.

Also, in May 2022, Bayer Korea started marketing MEDRAD Centargo, a computed tomography (CT) injection medical device, which received approval from the Ministry of Food and Drug Safety in January. Similarly, Ulrich Medical, a German medical technology company, presented a version of its CT motion contrast media injector designed for the American market at the RSNA in Chicago in May 2020. It was approved by the FDA and marketed in collaboration with GE Healthcare.

Therefore, owing to the above-mentioned factors, the demand for CT injector systems surges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global contrast media injectors market during the forecast period.

North America Is Expected To Dominate The Overall Contrast Media Injectors Market:

Among all the regions, North America is expected to dominate global contrast media injectors in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the rising demand for minimally invasive surgeries in the region as the minimally invasive surgical procedures with contrast media injectors deliver high-quality real-time imaging of the surgical site, and ensure that surgeons are treating the appropriate area. Further, the increasing burden of chronic diseases, presence of contrast media injectors manufacturer's hub in the US, rising product launches and approvals, favorable reimbursement scenarios, and others act as supportive factors for the North America contrast media injectors market growth.

For instance, as per the data provided by the American Cancer Society, it is estimated that in 2023, nearly 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States.

According to the CDC data updated in 2022, chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. They also contribute to USD 3.8 trillion in annual healthcare costs. Six in 10 adults in the country have a chronic disease, and four in every 10 have two or more chronic diseases. Additionally, according to Heart Disease & Stroke Statistical Fact Sheet 2020, a minimum of 40,000 infants are expected to be affected yearly by congenital heart defects in the United States. About 25% or 2.4 (per 1,000 live births) require treatment in the first year of an infant's life.

Thus, the increasing prevalence of various chronic diseases will increase the demand for contrast media injectors as these injectors are usually employed during the diagnosis of the above-mentioned diseases. Therefore, the increasing prevalence of chronic diseases will propel the market of contrast media injectors during the forecast period.

Additionally, countries such as the U.S. and Canada have seen an increase in hospital admissions in recent years, as a result of the high occurrence of chronic medical diseases & fatal injuries.

The surging product launches and approvals in the region will in turn propel the overall market. For instance, in July 2022, Ulrich received FDA approval for the ulrichINJECT CT motion. The ulrichINJECT CT motion system consists of the CT motion terminal, CT motion injector, and CT motion tubing system. Also, in November 2022, GE Healthcare and Ulrich Medical announced an agreement to offer a branded multi-dose contrast media injector in the United States.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North America region in the contrast media injectors market.

Contrast Media Injectors Market Key Players:

Some of the key market players operating in the contrast media injectors market include GE HealthCare, Bracco, MEDTRON AG, Ulrich GmbH & Co. KG, Bayer Pharmaceuticals, Nemoto Kyorindo co., Ltd., SINO MDT, APOLLO RT Co. Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., HONG KONG MEDI CO LIMITED, and others.

Recent Developmental Activities in the Contrast Media Injectors Market:

In December 2022, Guerbet and Bracco Imaging announced a global collaboration for Gadopiclenol, a next-generation magnetic resonance imaging (MRI) contrast agent.

In December 2022, Qaelum NV announced a strategic partnership with Ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with Ulrich Medical's contrast media injectors to support the needs of hospitals and imaging networks.

Key Takeaways from the Contrast Media Injectors Market Report Study

Market size analysis for current contrast media injectors market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the contrast media injectors market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global contrast media injectors market.

Various opportunities are available for the other competitor in the contrast media injector's market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current contrast media injector's market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for contrast media injector's market growth in the coming future?

Target Audience who can be benefited from this Contrast Media Injectors Market Report Study

Contrast media injectors products providers

Research organizations and consulting companies

Contrast media injectors- related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing, in contrast media injectors

Various end users who want to know more about the contrast media injectors market and the latest technological developments in the contrast media injectors market.

Frequently Asked Questions for the Contrast Media Injectors Market:

1. What are contrast media injectors?

Contrast media injectors (CMI) are devices employed for injecting contrast media into the body to improve the visibility of tissues for medical imaging procedures.

2. What is the global market for contrast media injectors?

The global contrast media injectors market was valued at USD 1,172 million in 2022 and is likely to register a CAGR of 4.27% during the forecast period from 2024 to 2030 to reach USD 1,504 million by 2030.

3. What are the drivers for the global contrast media injectors market?

The contrast media injectors market is witnessing positive market growth owing to the factors such as the increasing demand for minimally invasive surgeries, rising prevalence of chronic disorders, technological advancements and an increasing number of regulatory approvals, increasing product launches and approvals, and others will create an exigency for the contrast media injectors market.

4. Who are the key players operating in the global contrast media injectors market?

Some of the key market players operating in the contrast media injectors market include GE HealthCare, Bracco, MEDTRON AG, Ulrich GmbH & Co. KG, Bayer Pharmaceuticals, Nemoto Kyorindo co., Ltd., SINO MDT, APOLLO RT Co. Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., HONG KONG MEDI CO LIMITED, and others.

5. Which region has the highest share of the contrast media injectors market?

Among all the regions, North America is estimated to amass a significant revenue share in the global contrast media injectors market. This can be ascribed to the rising demand for minimally invasive surgeries, increasing burden of chronic diseases, presence of contrast media injectors manufacturer's hub in the US, rising product launches and approvals, and others act as a supportive factor for the North American contrast media injectors market growth.

Table of Contents

1.Contrast Media Injectors Market Report Introduction

2. Contrast Media Injectors Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Contrast Media Injectors Market Key Factors Analysis

  • 4.1. Contrast Media Injectors Market Drivers
    • 4.1.1. Increasing demand for minimally invasive surgeries
    • 4.1.2. Rising prevalence of chronic disorders
    • 4.1.3. Technological Advancements and Increasing Number of Regulatory Approvals
  • 4.2. Contrast Media Injectors Market Restraints and Challenges
    • 4.2.1. High cost of contrast media injectors and consumables
    • 4.2.2. Adverse effects of contrast agents
  • 4.3. Contrast Media Injectors Market Opportunities
    • 4.3.1. IT-driven platforms for contrast media injectors

5. Contrast Media Injectors Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Contrast Media Injectors Market

7. Contrast Media Injectors Market Layout

  • 7.1. By Product
    • 7.1.1. Injector Systems
      • 7.1.1.1. CT Injector Systems
      • 7.1.1.2. MRI Injector Systems
      • 7.1.1.3. Cardiovascular/Angiography Injector Systems
    • 7.1.2. Consumables
      • 7.1.2.1. Tubing
      • 7.1.2.2. Syringe
      • 7.1.2.3. Other
  • 7.2. By Type of Injectors
    • 7.2.1. Single-head Injectors
    • 7.2.2. Dual-head Injectors
    • 7.2.3. Syringeless Injectors
  • 7.3. By Application
    • 7.3.1. Radiology
    • 7.3.2. Interventional Cardiology
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.1.2. Canada Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.1.3. Mexico Contrast Media Injectors Market in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.2. Germany Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.4. Italy Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.5. Spain Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Contrast Media Injectors Market in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.2. Japan Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.3. India Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.4. Australia Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.5. South Korea Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Contrast Media Injectors Market in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.4.2. Africa Contrast Media Injectors Market in USD million (2021-2030)
      • 7.4.4.3. South America Contrast Media Injectors Market in USD million (2021-2030)

8. Contrast Media Injectors Market Company and Product Profiles

  • 8.1. GE HealthCare
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Bracco
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. MEDTRON AG
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Ulrich GmbH & Co. KG
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Bayer Pharmaceuticals
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Nemoto Kyorindo co., Ltd.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. SINO MDT
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. APOLLO RT Co. Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Shenzhen Seacrown Electromechanical Co., Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. HONG KONG MEDI CO LIMITED
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us